An engineered self-inactivating adeno-associated virus mediated Cas9 delivery system for therapeutic genome editing

被引：0
|
作者：
Fuentes, C. M. [1 ]
Chen, A. [1 ]
Schaffer, D. V. [1 ]
机构：
[1] Univ Calif Berkeley, Berkeley, CA 94720 USA
来源：
HUMAN GENE THERAPY | 2019年 / 30卷 / 11期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
P564
引用
收藏
页码：A183 / A183
页数：1
相关论文
共 50 条
  • [1] Genome editing with a self-inactivating CRISPR/Cas9 system for neurodegenerative diseases
    Vachey, G.
    Merienne, N.
    Meunier, C.
    Zimmer, V.
    Perriard, G.
    Canales, M.
    Mathias, A.
    Hergott, L.
    Beltraminelli, T.
    Dequesne, T.
    Pythoud, C.
    Rey, M.
    Pellerin, L.
    du Pasquier, R.
    Deglon, N.
    HUMAN GENE THERAPY, 2016, 27 (11) : A48 - A48
  • [2] Adeno-associated virus-mediated delivery of CRISPR-Cas9 for genome editing in the central nervous system
    Fuentes, Christina Marie
    Schaffer, David Vernon
    CURRENT OPINION IN BIOMEDICAL ENGINEERING, 2018, 7 : 33 - 41
  • [3] All-in-one adeno-associated virus delivery and genome editing by Neisseria meningitidis Cas9 in vivo
    Raed Ibraheim
    Chun-Qing Song
    Aamir Mir
    Nadia Amrani
    Wen Xue
    Erik J. Sontheimer
    Genome Biology, 19
  • [4] All-in-one adeno-associated virus delivery and genome editing by Neisseria meningitidis Cas9 in vivo
    Ibraheim, Raed
    Song, Chun-Qing
    Mir, Aamir
    Amrani, Nadia
    Xue, Wen
    Sontheimer, Erik J.
    GENOME BIOLOGY, 2018, 19
  • [5] Engineering a Self-Inactivating Adeno-Associated Virus (AAV) Vector for ARCUS Nuclease Delivery
    Li, Hui
    Mefferd, Adam
    Lape, Janel
    Morris, John
    Smith, Jeff
    MOLECULAR THERAPY, 2020, 28 (04) : 290 - 291
  • [6] Advances in Genome Editing Using Adeno-Associated Virus Delivery of a Compact, Hyper-Accurate Cas9 with a Dinucleotide PAM
    Ibraheim, Raed R.
    Edraki, Alireza
    Mir, Aamir
    Gainetdinov, Ildar
    Yoon, Yeonsoo
    Song, Chun-Qing
    Xue, Wen
    Rivera-Perez, Jaime A.
    Sontheimer, Erik
    MOLECULAR THERAPY, 2019, 27 (04) : 447 - 447
  • [7] Allele-specific gene editing for Huntington's disease mediated by a self-inactivating CRISPR/Cas9 system
    Vachey, G.
    Regio, S.
    Buron, J.
    Donat, T.
    Ouared, A.
    Stibolt, C.
    Kocher, J.
    Ferreira, A.
    Deglon, N.
    HUMAN GENE THERAPY, 2018, 29 (12) : A83 - A84
  • [8] Delivery of CRISPR/Cas9 for therapeutic genome editing
    Xu, Xiaojie
    Wan, Tao
    Xin, Huhu
    Li, Da
    Pan, Hongming
    Wu, Jun
    Ping, Yuan
    JOURNAL OF GENE MEDICINE, 2019, 21 (07):
  • [9] ALLELE SPECIFIC GENE EDITING FOR HUNTINGTON'S DISEASE MEDIATED BY THE KAMICAS9 SELF-INACTIVATING CRISPR/CAS9 SYSTEM
    Deglon, Nicole
    Vachey, Gabriel
    Rey, Maria
    Perrier, Anselme
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 : A90 - A90
  • [10] CRISPR/Cas9 Delivery System Engineering for Genome Editing in Therapeutic Applications
    Cheng, Hao
    Zhang, Feng
    Ding, Yang
    PHARMACEUTICS, 2021, 13 (10)
12345